LIPO Stock Price | Lipella Pharmaceuticals Inc. Common Stock P/E, Revenue, EPS, & Forecasts

Lipella Pharmaceuticals Inc. Common Stock • LIPO

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Lipella Pharmaceuticals Inc. Common Stock

Ticker

LIPO

Trading on

NASDAQ

ISIN

US53630L2097

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Jonathan Kaufman M.B.A., Ph.D.

Headquarters

7800 Susquehanna St., Pittsburgh, PA, United States, 15208

Employees

Website

https://lipella.com

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It develops LP-10, a formulation of tacrolimus for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; LP-410, an oral liposomal formulation of tacrolimus to treat oral graft-versus-host disease; and LP-50, an intravesical formulation of immunoglobulins for the treatment of non-muscle invasive bladder cancer. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania.

Metrics

BasicAdvanced

Market cap

$1.7M

P/E ratio

EPS

-$3.33

Dividend Yield

0.00%

Beta

-0.08

Forward P/E ratio

EBIDTA

$-5.6M

Ex dividend date

Price & volume

Market cap

$1.7M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

3.6

Price to book

0.94

Earnings

EPS

-$3.33

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-5.6M

Revenues (TTM)

$0.5M

Revenues per share (TTM)

$0.22

Technicals

Beta

-0.08

52-week High

$4.69

52-week Low

$0.37

50-day moving average

$0.57

200-day moving average

$1.73

Short ratio

3.32

Short %

2.35%

Management effectiveness

ROE (TTM)

-248.36%

ROA (TTM)

-118.45%

Profit margin

0.00%

Gross profit margin

$-3.4M

Operating margin

-1,564.19%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

-36.40%

Share stats

Outstanding Shares

4.6M

Float

4.3M

Insiders %

6.53%

Institutions %

1.35%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$10.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$1.29

-$0.96

-34.38%

Q3 • 24Missed

-$1.19

-$2.43

51.03%

Q4 • 24Beat

-$0.64

Q1 • 25Beat

-$0.31

Q2 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$129M

$-1.31B

-1,009.76%

Q1 • 25

$86.7M

$-1.3M

-1.53%

Q2 • 25

-32.97%

-99.90%

-99.85%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$4.9M

$0.8M

16.00%

Q1 • 25

$3.7M

$1M

26.30%

Q2 • 25

-23.39%

25.96%

64.42%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.43B

$0M

$3.5M

$-1.43B

Q1 • 25

$-1.4M

$0M

$-0M

$-1.4M

Q2 • 25

-99.90%

-100.29%

-99.90%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Lipella Pharmaceuticals Inc. Common Stock share?

Lipella Pharmaceuticals Inc. Common Stock shares are currently traded for undefined per share.

How many shares does Lipella Pharmaceuticals Inc. Common Stock have?

Lipella Pharmaceuticals Inc. Common Stock currently has 4.6M shares.

Does Lipella Pharmaceuticals Inc. Common Stock pay dividends?

No, Lipella Pharmaceuticals Inc. Common Stock doesn't pay dividends.

What is Lipella Pharmaceuticals Inc. Common Stock 52 week high?

Lipella Pharmaceuticals Inc. Common Stock 52 week high is $4.69.

What is Lipella Pharmaceuticals Inc. Common Stock 52 week low?

Lipella Pharmaceuticals Inc. Common Stock 52 week low is $0.37.

What is the 200-day moving average of Lipella Pharmaceuticals Inc. Common Stock?

Lipella Pharmaceuticals Inc. Common Stock 200-day moving average is $1.73.

Who is Lipella Pharmaceuticals Inc. Common Stock CEO?

The CEO of Lipella Pharmaceuticals Inc. Common Stock is Dr. Jonathan Kaufman M.B.A., Ph.D..

How many employees Lipella Pharmaceuticals Inc. Common Stock has?

Lipella Pharmaceuticals Inc. Common Stock has 5 employees.

What is the market cap of Lipella Pharmaceuticals Inc. Common Stock?

The market cap of Lipella Pharmaceuticals Inc. Common Stock is $1.7M.

What is the P/E of Lipella Pharmaceuticals Inc. Common Stock?

The current P/E of Lipella Pharmaceuticals Inc. Common Stock is null.

What is the EPS of Lipella Pharmaceuticals Inc. Common Stock?

The EPS of Lipella Pharmaceuticals Inc. Common Stock is -$3.33.

What is the PEG Ratio of Lipella Pharmaceuticals Inc. Common Stock?

The PEG Ratio of Lipella Pharmaceuticals Inc. Common Stock is null.

What do analysts say about Lipella Pharmaceuticals Inc. Common Stock?

According to the analysts Lipella Pharmaceuticals Inc. Common Stock is considered a buy.